1. Home
  2. RNST vs CORT Comparison

RNST vs CORT Comparison

Compare RNST & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$38.88

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$36.07

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
CORT
Founded
1904
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.7B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
RNST
CORT
Price
$38.88
$36.07
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$42.25
$105.20
AVG Volume (30 Days)
699.2K
1.8M
Earning Date
04-27-2026
05-25-2026
Dividend Yield
2.44%
N/A
EPS Growth
27.73
N/A
EPS
1.20
0.82
Revenue
N/A
$761,407,000.00
Revenue This Year
$31.83
$30.63
Revenue Next Year
$4.58
$31.61
P/E Ratio
$31.39
$43.22
Revenue Growth
N/A
12.79
52 Week Low
$27.26
$28.66
52 Week High
$42.11
$117.33

Technical Indicators

Market Signals
Indicator
RNST
CORT
Relative Strength Index (RSI) 48.49 38.35
Support Level $37.45 $33.53
Resistance Level $39.91 $41.92
Average True Range (ATR) 1.29 2.51
MACD -0.35 0.36
Stochastic Oscillator 42.19 56.26

Price Performance

Historical Comparison
RNST
CORT

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: